Mitochondria morphology and DNA content upon sublethal exposure to beta-amyloid1-42 peptide

Brains affected by Alzheimer's disease (AD) show a large spectrum of mitochondrial alterations at both morphological and genetic level. The causal link between amyloid beta peptides (Aß) and mitochondrial dysfunction has been established in cellular models of AD using Aß concentrations capable...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Collegium antropologicum 2008-01, Vol.32 (Supp.), p.51-58
Hauptverfasser: Diana, A, Simic, G, Sinforiani, E, Orrù, N, Pichiri, G, Bono, G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Brains affected by Alzheimer's disease (AD) show a large spectrum of mitochondrial alterations at both morphological and genetic level. The causal link between amyloid beta peptides (Aß) and mitochondrial dysfunction has been established in cellular models of AD using Aß concentrations capable of triggering massive neuronal death. However, mitochondrial changes related to sublethal exposure to Aß are less known. Here we show that subtoxic, 1 µM Aß1-42 exposure does not change the mitochondrial shape of living cells, as visualized upon the uptake of the non-potentiometric fluorescent probe Mitotracker Green and enhanced yellow fluorescent protein (EYFP)-tagged cytochrome e oxidase expression. Immunolocalization of oxidative adducts 8-hydroxy-2'-deoxyguanosine, 8-hydroxyguanine and 8-hydroxyguanosine demonstrates that one-micromolar concentration of Aß1-42 is also not sufficient to elicit dramatic qualitative changes in the RNA/DNA oxidative products. However, in comparison with controls, semi-quantitative analysis of the overall mitochondrial mass by integrated fluorescence intensity reveals an ongoing down-regulation in mitochondrial biosynthesis or, conversely, an enhanced autophagic demise of Aß treated cells. Furthermore, a significant increase of the full-length mitochondrial DNA (mtDNA) from Aß-treated versus control cells is found, as measured by long range polymerase chain reaction (PCR). Such up-regulation is accompanied by extensive fragmentation of the unamplified mtDNA, probably due to the detrimental effect of Aß. We interpret these results as a sequence of compensatory responses induced by mtDNA damage, which are devoted to repression of oxidative burst. In conclusion, our findings suggest that early therapeutic interventions aimed at prevention of mitochondrial oxidative damage may delay AD progression and help in treating AD patients. Reprinted by permission of Croatian Anthropological Society and Institute for Anthropological Research, Zagreb, Croatia
ISSN:0350-6134